Related Experiment Video
Updated: Aug 5, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Impaired left atrial strain is associated with acute ischemic stroke in patients without atrial fibrillation
Robert Trueick1, Jonathan Shpigelman2, Omar Dabash3
1Department of Cardiology, Connolly Hospital, Dublin, Ireland.
Insights
Left atrial conduit strain (LAScd) impairment is linked to acute ischemic stroke (AIS) in patients without known high-risk factors. This finding suggests LAScd may help identify individuals needing preventive strategies for stroke risk.
Area of Science:
- Cardiology
- Neurology
- Echocardiography
Background:
- Cryptogenic stroke presents a significant clinical challenge due to its unknown cause.
- Left atrial dysfunction, assessed by left atrial strain (LAS), may predict acute ischemic stroke (AIS) risk, even without atrial fibrillation (AF).
Purpose of the Study:
- To evaluate the association of left atrial strain (LAS) with prevalent and incident acute ischemic stroke (AIS) in patients without high-risk stroke mechanisms.
- To determine if LAS can serve as a biomarker for stroke risk stratification.
Main Methods:
- Retrospective study of patients with positive Face Arm Speech Test (FAST) results and no high-risk stroke mechanisms.
- Transthoracic echocardiography with speckle-tracking used to measure LAS in reservoir (LASr), conduit (LAScd), and contractile (LASct) phases.
- Multivariable logistic and Cox regression analyses to assess associations with prevalent and incident AIS.
Main Results:
- Both LASr and LAScd were independently associated with AIS at presentation.
- During follow-up, worsening tertiles of LASr and LAScd correlated with increased AIS incidence.
- LAScd remained independently associated with incident AIS, suggesting its prognostic value.
Conclusions:
- Impaired LAScd is independently associated with prevalent and incident AIS in patients without identified high-risk stroke mechanisms.
- LAScd may be a valuable tool for risk stratification and guiding preventive strategies in this population.
- Further prospective studies are warranted to confirm these findings.
Background:
Cryptogenic stroke, defined as a stroke with an unknown cause, poses a significant clinical challenge in cardiology and neurology. Left atrial (LA) dysfunction, as measured by left atrial strain (LAS), may identify patients who are at high risk for acute ischemic stroke (AIS), even if they do not have documented atrial fibrillation (AF).
Methods:
This retrospective, cross-sectional and cohort study (known as the ASSISTANT Study) was conducted at a single, tertiary-care referral center. The study included patients who tested positive on the Face Arm Speech Test (FAST) and who did not have high-risk stroke mechanisms. These patients presented acutely and underwent a transthoracic echocardiogram. Speckle-tracking echocardiography was used to measure LAS in three phases: reservoir (LASr), conduit (LAScd), and contractile (LASct). The associations of LAS with imaging-confirmed acute ischemic stroke (AIS) at presentation and incident AIS during follow-up were evaluated using multivariable logistic and Cox regression analyses, respectively.
Results:
Among the 415 patients (251 cases and 164 controls), LASr and LAScd were both independently associated with AIS at presentation [OR per 5% increase: 0.789 (95% CI, 0.674-0.920) and 0.573 (95% CI, 0.450-0.718), respectively]. During a median follow-up of 3.59 years, 31 patients developed incident AIS. The incidence of AIS increased as the tertiles of LASr (P trend = 0.021) and LAScd (P trend < 0.001) worsened. Only LAScd remained independently associated with incident AIS [HR per 5% increase: 0.682 (95% CI, 0.478-0.953)].
Conclusion:
Impaired LAScd is independently associated with prevalent and incident AIS in patients without identified high-risk stroke mechanisms. Prospective studies are needed to determine whether LAScd can guide risk stratification and preventive strategies in this patient population.
Trial Registration:
ClinicalTrials.gov (NCT07102693).
Related Concept Videos
Ischemic Stroke l: Introduction
Mitral Stenosis I: Introduction
Ischemic Stroke ll: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Transient Ischemic Attack l: Introduction